SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors

MacCollin, 2005, Diagnostic criteria for schwannomatosis, Neurology, 64, 1838, 10.1212/01.WNL.0000163982.78900.AD

Mulvihill, 1990, NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update, Ann Intern Med, 113, 39, 10.7326/0003-4819-113-1-39

Smith, 2011, Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset, J Med Genet, 48, 261, 10.1136/jmg.2010.085241

Evans, 1999, Paediatric presentation of type 2 neurofibromatosis, Arch Dis Child, 81, 496, 10.1136/adc.81.6.496

van den Munckhof, 2012, Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri, Neurogenetics, 13, 1, 10.1007/s10048-011-0300-y

Boyd, 2008, Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis, Clin Genet, 74, 358, 10.1111/j.1399-0004.2008.01060.x

Hadfield, 2008, Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis, J Med Genet, 45, 332, 10.1136/jmg.2007.056499

Evans, 2007, Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification, J Med Genet, 44, 424, 10.1136/jmg.2006.047753

MacCollin, 2003, Familial schwannomatosis: exclusion of the NF2 locus as the germline event, Neurology, 60, 1968, 10.1212/01.WNL.0000070184.08740.E0

Hulsebos, 2007, Germline mutation of INI1/SMARCB1 in familial schwannomatosis, Am J Hum Genet, 80, 805, 10.1086/513207

Sestini, 2008, Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas, Hum Mutat, 29, 227, 10.1002/humu.20679

Sevenet, 1999, Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations, Hum Mol Genet, 8, 2359, 10.1093/hmg/8.13.2359

Sevenet, 1999, Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers, Am J Hum Genet, 65, 1342, 10.1086/302639

Eaton, 2011, Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors, Pediatr Blood Cancer, 56, 7, 10.1002/pbc.22831

Swensen, 2009, Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1, J Med Genet, 46, 68, 10.1136/jmg.2008.060152

Carter, 2012, Epithelioid malignant peripheral nerve sheath tumor arising in a schwannoma, in a patient with “neuroblastoma-like” schwannomatosis and a novel germline SMARCB1 mutation, Am J Surg Pathol, 36, 154, 10.1097/PAS.0b013e3182380802

Smith, 2009, Identity analysis of schwannomatosis kindreds with recurrent constitutional SMARCB1 (INI1) alterations, Clin Genet, 75, 501, 10.1111/j.1399-0004.2009.01156.x

Smith, 2012, Expression of SMARCB1 (INI1) mutations in familial schwannomatosis, Hum Mol Genet, 21, 5239, 10.1093/hmg/dds370

Schmitz, 2001, INI1 mutations in meningiomas at a potential hotspot in exon 9, Br J Cancer, 84, 199, 10.1054/bjoc.2000.1583

Bourdeaut, 2011, Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor, Clin Cancer Res, 17, 31, 10.1158/1078-0432.CCR-10-1795

Gonzalvo, 2011, Schwannomatosis, sporadic schwannomatosis, and familial schwannomatosis: a surgical series with long-term follow-up. Clinical article, J Neurosurg, 114, 756, 10.3171/2010.8.JNS091900

Murray, 2006, A case of multiple cutaneous schwannomas; schwannomatosis or neurofibromatosis type 2?, J Neurol Neurosurg Psychiatry, 77, 269, 10.1136/jnnp.2005.067017

Baser, 2006, Increasing the specificity of diagnostic criteria for schwannomatosis, Neurology, 66, 730, 10.1212/01.wnl.0000201190.89751.41

Piotrowski, 2014, Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas, Nat Genet, 46, 182, 10.1038/ng.2855

Hadfield, 2010, Differences in rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas, Oncogene, 29, 6216, 10.1038/onc.2010.363

Evans, 2006, Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes, J Med Genet, 43, 289, 10.1136/jmg.2005.036319